In Re: Ariad Pharmaceuticals

Summary

Hearing on motion to dismiss.

"The Complaint principally asserts that (1) Director Defendants Dr. Berger and Mr. LaMarche violated their fiduciary duties by disagreeing with the majority of other directors (the "Resigning Directors" and Dr. Lavidas) over the appropriate course for the Company to take in regard to acquiring the minority interest in ARIAD Gene Therapeutics, Inc. ("AGTI" that it did not already own, (2) all of the Director Defendants breached their fiduciary duties by voting in favor of an administrative change that resulted in one of the Resigning Directors no longer having the title of "vice chairman," and (3) Dr. Berger violated his duties by allegedly terminating the former in-house general counsel"

View a free video clip from the case:
Jack Sylvia argues on behalf of the nominal defendant, Ariad Pharma -- Clip 1